Comparing two techniques for treating knee osteoarthritis
Comparison of Integrated Neuromuscular Inhibition Technique and Dry Needling on Trigger Points in Patient With Knee Osteoarthritis
This study is testing whether a new treatment technique called Integrated Neuromuscular Inhibition Technique works better than Dry Needling for people with knee osteoarthritis.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 36 (estimated) |
| Ages | 40 Years to 60 Years |
| Sex | All |
| Sponsor | Riphah International University Academic / other |
| Locations | 1 site (Rawalpindi, Punjab Province) |
| Trial ID | NCT06437730 on ClinicalTrials.gov |
What this trial studies
This study aims to compare the effects of Integrated Neuromuscular Inhibition Technique (INIT) and Dry Needling on patients with knee osteoarthritis. A randomized control trial will be conducted at Wah General Hospital in Taxila, involving 50 participants divided into two groups. The study will assess functional disability, pain levels, and range of motion using various tools such as Goniometer, NPRS, and WOMAC. Data will be collected before and immediately after the interventions and analyzed using SPSS.
Who should consider this trial
Good fit: Ideal candidates for this study are individuals with Grade 1 to 2 knee osteoarthritis who exhibit a positive jump sign in specific muscle groups.
Not a fit: Patients with rheumatoid arthritis, autoimmune disorders, or those with a history of significant trauma or surgery to the knee may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide effective treatment options for reducing pain and improving function in patients with knee osteoarthritis.
How similar studies have performed: Other studies have shown promising results with similar techniques for treating musculoskeletal pain, suggesting potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Osteoarthritis Grade-1 to 2 Positive jump sign Vastus medialis(75.43%), Vastus laterals(65.78%), Gastrocnemius Exclusion Criteria: * Patient with history of RA or any autoimmune disorder Any systematic Illness Patient with Varicose vein Post traumatic, Post-Surgical and Post fractured
Where this trial is running
Rawalpindi, Punjab Province
- Wah General Hospital, — Rawalpindi, Punjab Province, Pakistan (Recruiting)
Study contacts
- Principal investigator: Lal Gul Khan, MScPT — Riphah International University
- Study coordinator: Imran Amjad, PhD
- Email: imran.amjad@riphah.edu.pk
- Phone: 03324390125
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.